INTERNATIONAL PATENT: MERCK PATENT GMBH FILES APPLICATION FOR "ANTI-GD2 ANTIBODIES AND IMMUNOCONJUGATES FOR THE TREATMENT OF GD2 POSITIVE CANCER"

GENEVA, Aug. 25 -- MERCK PATENT GMBH (Frankfurter Strasse 25064293 Darmstadt) filed a patent application (PCT/EP2025/054015) for "ANTI-GD2 ANTIBODIES AND IMMUNOCONJUGATES FOR THE TREATMENT OF GD2 POSITIVE CANCER" on Feb 14, 2025. With publication no. WO/2025/172525, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AMENDT, Christiane (c/o Merck Healthcare KGaAFrankfurter Strasse 25064293 Darmstadt), KNUEHL, Christine (c/o Merck Healthcare KGaAFrankfurter Strasse 25064293 Darmstadt), DOTTERWEICH, Julia (c/o Merck Healthcare ...